A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit-Reference-Cited by-同舟云学术

A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit

Published:2015-05-31 Issue:9 Volume:64 Page:1123-1136
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Anastasopoulou Eleftheria A.,Voutsas Ioannis F.,Keramitsoglou Theodora,Gouttefangeas Cécile,Kalbacher Hubert,Thanos Anastasios,Papamichail Michael,Perez Sonia A.,Baxevanis Constantin N.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-015-1717-1.pdf

Reference42 articles.

1. Schlom J (2012) Therapeutic cancer vaccines: current status and moving forward. J Natl Cancer Inst 104:599–613. doi: 10.1093/jnci/djs033

2. Cheng ML, Fong L (2014) Beyond sipuleucel-T: immune approaches to treating prostate cancer. Curr Treat Options Oncol 15:115–126. doi: 10.1007/s11864-013-0267-z

3. May KF Jr, Gulley JL, Drake CG, Dranoff G, Kantoff PW (2011) Prostate cancer immunotherapy. Clin Cancer Res 17:5233–5238. doi: 10.1158/1078-0432.CCR-10-3402

4. Baxevanis CN (2012) Outlining novel scenarios for improved therapeutic cancer vaccines: the PANVAC paradigm. Expert Rev Vaccines 11:275–277. doi: 10.1586/erv.11.193

5. Hoos A, Eggermont AM, Janetzki S et al (2010) Improved endpoints for cancer immunotherapy trials. J Natl Cancer Inst 102:1388–1397. doi: 10.1093/jnci/djq310

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of potential prognostic genes associated with the tumor microenvironment in chromophobe renal cell carcinoma based on weighted gene co-expression network analysis;2024-02-20

2. Association of HLA-A*11:01, -A*24:02, and -B*18:01 with Prostate Cancer Risk: A Case-Control Study;International Journal of Molecular Sciences;2023-10-20

3. Prediction and Classification of Different Cancer Gene Using MD and PCA-MD Method;Transactions of the Indian National Academy of Engineering;2023-08-09

4. Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities;Vaccines;2021-06-09

5. Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer;Cancers;2021-01-06